InvestorsHub Logo
Followers 17
Posts 10878
Boards Moderated 0
Alias Born 03/11/2017

Re: None

Wednesday, 02/28/2018 1:34:20 PM

Wednesday, February 28, 2018 1:34:20 PM

Post# of 44784
When You Are In Possession Of A Multi-Generational Disruptive Medical Platform Technology.


That Will Single-Handedly Change The World Of Medicine In A Very Profound Way. The "PLX-Cell Living Drug Approach" That Is Able To Diagnose/Develop/Deliver The Precise Amount And Kinds Of Cytokines/Chemokine's Etc. To Treat A Multitude Of Indications.


There Is No Way In Hell, Big Pharma Is Going To Miss-Out On That Global Paradigm Shift To Living Drugs. Therefore They Must Do By What-Ever Legal Means Possible & Necessary To Secure A Favorable Deal To Pluristem's Liking.

We Must Always Remember, Pluristem Knows What They Have And They Know Very Well It's Enormous Value. The One And Only String Big Pharma Has To Pull, In Order To Some How Gain Leverage With Pluristem During Negotiations, Is To Keep Reminding Them Of Their Very Low Stock Valuation. (Hence Their Need To Maintain A Low PPS)


A Tactic That IMO, Has Not Worked For Big Pharma In 2 Years And Will Never Work. As I Believe Pluristem Has Them Beat At Every Angle. IMO..Zami & Yaky Know Exactly What They Are Doing And When The Deal(s) Finally Gets Done, Shareholders Will Weep With Joy ! It Is Only Then... That Their Critics Will Begin To Fully Appreciate Their Tenacity And Forward-Thinking Business Acumen ! Allo~